Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

121 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

NCT02933320

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Leicester Royal Infirmary Leicester, England, United Kingdom
  • Christie Hospital Manchester, England, United Kingdom
  • Oxford Cancer and Haematology Centre, Churchill Hospital Oxford, England, United Kingdom
  • Derriford Hospital Plymouth, United Kingdom
View Trial Details
Completed

Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL

NCT01659255

Conditions
Chronic Lymphocytic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • CHRU - Hopital Claude HURIEZ Lille, France
  • Centre hospitalier Lyon Sud Lyon, France
  • CHU St Eloi Montpellier, France
  • University Hospital of Wales Cardiff, United Kingdom
View Trial Details
Completed

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

NCT00824265

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Novartis Investigative Site Boca Raton, Florida, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Clinton, Maryland, United States
  • Novartis Investigative Site Kansas City, Missouri, United States
View all 135 locations
View Trial Details
Completed

Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

NCT01109069

Conditions
B Cell Lymphoma, B-Cell Diffuse Lymphoma, B-cell Chronic Lymphocytic Leukemia, +41 more
Locations
  • Stanford University Stanford, California, United States
  • Stanford, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Completed

Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

NCT01732861

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Clearview Cancer Institute Oncology Specialties, P.C Huntsville, Alabama, United States
  • Horizon Oncology Center Lafayette, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Mount Sinai School of Medicine New York, United States
View Trial Details
Completed

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

NCT00419250

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
View all 35 locations
View Trial Details

Related conditions